Featured Posters & Presentations
Lyfgenia
Gene transduction, hematopoietic stem cells (HSC) engraftment, and red blood cell (RBC) physiology in sickle cell disease (SCD) gene therapy.
Authors: Bonner M.
Lyfgenia
Resolution of sickle cell disease (SCD) manifestations in patients treated with LentiGlobin gene therapy: Updated results from the Phase 1/2 HGB-206 Group C study.
Authors: Tisdale JF.